TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Djurfarmacia Sverige AB
Closing information (x1000 EUR)
Closing information | 2023/08 | 2022/08 | 2021/08 |
Turnover |
35,383
|
33,776
|
32,307 |
Financial expenses |
24
|
4
|
0 |
Earnings before taxes |
1,677
|
1,958
|
2,241 |
EBITDA |
1,939
|
2,040
|
2,494 |
Total assets |
9,214
|
9,640
|
7,968 |
Current assets |
7,167
|
7,411
|
7,833 |
Current liabilities |
4,140
|
4,204
|
3,387 |
Equity capital |
4,681
|
4,659
|
4,156 |
- share capital |
8
|
9
|
10 |
Employees (average) |
53
|
47
|
42 |
Financial ratios
Fiscal year | 2023/08 | 2022/08 | 2021/08 |
Solvency |
50.8%
|
48.3%
|
52.2% |
Turnover per employee |
668
|
719
|
769 |
Profit as a percentage of turnover |
4.7%
|
5.8%
|
6.9% |
Return on assets (ROA) |
18.5%
|
20.4%
|
28.1% |
Current ratio |
173.1%
|
176.3%
|
231.3% |
Return on equity (ROE) |
35.8%
|
42.0%
|
53.9% |
Change turnover |
4,918
|
3,049
|
5,222 |
Change turnover % |
16%
|
10%
|
19% |
Chg. No. of employees |
6
|
5
|
8 |
Chg. No. of employees % |
13%
|
12%
|
24% |
Total value of public sale
Fiscal year | 2023/08 | 2022/08 | 2021/08 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.